Cell Therapy & Gene Therapy Equipment calculator
Cell Therapy Capacity Gap Calculator
Capacity in cell and gene therapy is not what your equipment is scheduled to make; it is what actually passes release after downtime and yield losses. This calculator turns gross scheduled capacity (output per cycle x available cycles) into usable released capacity by discounting for equipment availability and release yield, then shows you exactly how many units you lose to each. Capacity planners, supply chain leads, and site directors use it to set realistic patient-supply commitments and to see whether the binding constraint is uptime or release. It matters because committing to a gross number you cannot release is how cell therapy programs miss patient delivery windows.
What this calculator does
- Estimate the gap between required production demand and usable cell therapy or gene therapy equipment capacity.
- a production planner needs to know whether current GMP equipment can cover forecast batch or dose demand
- It calculates usable released capacity from scheduled cycles after applying equipment availability and lot release yield, and isolates the units lost to each factor.
Formula used
- Gross scheduled capacity = qualified output per cycle × available equipment cycles
- Usable released capacity = gross scheduled capacity × equipment availability × released-output yield
Inputs explained
- Qualified released units per equipment cycle:
- Available equipment cycles in the period:
- Expected equipment uptime / availability:
- Expected lot release yield:
How to use the result
- Use it for capacity planning, demand commitments, and constraint analysis on a specific bioreactor, perfusion, or fill platform.
- It assumes availability and yield are independent steady-state percentages; a single catastrophic equipment failure or a comparability hold is not modeled by smooth percentages.
Current U.S. benchmarks
- U.S. manufacturing runs at 75.6% of capacity with new factory orders at $657B per month (Federal Reserve and Census, May 2026).
- Steel mill PPI stands at 348.53 (BLS, May 2026), up 6.7% from a year earlier. New factory orders are up 2.3% year over year (Census).
Common questions
- How do you calculate usable released capacity? Multiply qualified output per cycle by available cycles to get gross capacity, then multiply by equipment availability and by release yield. With 6 units/cycle, 80 cycles, 90% uptime, and 86% yield, usable released capacity is 371.52 units.
- What is the difference between gross and released capacity? Gross scheduled capacity (480 units here) assumes perfect uptime and 100% release. Released capacity (371.52 units) is what survives downtime and lot rejection, and is the only number safe to commit to patients.
- How much capacity is lost to downtime versus yield? In the example, equipment downtime costs 48 units and unreleased output costs 60.48 units. Here yield is the larger leak, so investment in release-rate improvement returns more units than chasing uptime.
- What is a good equipment availability for cell therapy? Single-use bioreactor trains often target 85-92% availability once a process is mature; the 90% default sits in that band. Lower values usually point to changeover, cleaning, or unplanned maintenance time.
- Why does release yield matter so much? Release yield is the fraction of produced lots that pass all specifications. At 86%, every gross unit only delivers 0.86 released units, which is why 60.48 units evaporated despite the equipment running.
Last reviewed 2026-05-12.